New crystal forms of sodium 2-(5-bro-4-(4-cyclopropylnaphthalene-1- yl)-4H-1,2,4-triazole-3-yl sulfenyl) acetate and preparation method thereof
A technology of cyclopropylnaphthalene and thiol, which is applied in the field of chemical medicine, can solve the problems of mesophase crystallinity, mixed amorphous, crystal transformation, etc., achieve good stability, and is conducive to long-term storage and placement. Simple operation effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0079] Example 1
[0080] Preparation of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) sodium acetate crystal form I:
[0081] Dissolve 200 mg of the amorphous form of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalene-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate in 1.0 mL Obtain a clear solution in pure water, stir at room temperature for 24 hours until a solid precipitates, collect the wet solid product and test XRPD to obtain crystal form I. Its XRPD diagram is like figure 1 As shown, the DSC chart is figure 2 As shown, the TGA diagram is as image 3 Shown.
[0082] Table 1 Powder X-ray diffraction data of crystal form Ⅰ
[0083] 2theta
[0084] 17.55
[0085] 28.77
Example Embodiment
[0086] Example 2
[0087] Preparation of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) sodium acetate crystal form II:
[0088] Dissolve 50 mg of the amorphous form of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate sodium in 0.5mL In the mixed system of ethyl acetate: water = 976:24 (v:v), stir at room temperature for more than 48 hours, and collect the solid to obtain crystal form II. Its XRPD diagram is like Figure 5 As shown, the DSC chart is Image 6 As shown, the TGA diagram is as Figure 7 Shown.
[0089] Table 2 X-ray powder diffraction data of crystal form Ⅱ
[0090] 2theta
[0091] 23.63
Example Embodiment
[0092] Example 3
[0093] Preparation of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) sodium acetate crystal form III:
[0094] 3.8 mg of 2-(5-bromo-4-(4-cyclopropylnaphthalene-1-yl)-4H-1,2,4-triazol-3-ylthio) sodium acetate was dissolved in an amorphous form in 2.0 In mL of ethyl acetate solvent, a clear solution was obtained, which was slowly volatilized at room temperature until a solid precipitated. The solid was collected to obtain crystal form III. Its XRPD diagram is like Picture 9 As shown, the DSC chart is Picture 10 As shown, the TGA diagram is as Picture 11 Shown.
[0095] Table 3 X-ray powder diffraction data of crystal form Ⅲ
[0096] 2theta
[0097] 20.05
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap